Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)

This study has been terminated.
(Slow accrual.)
Wake Forest University
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: December 19, 2003
Last updated: February 20, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2004
  Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)